WCM
BIIB icon

Winton Capital Management’s Biogen BIIB Stock Holding History

Winton Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		$30.8M Buy
100,854
+21,319
+27% +$6.77M 0.21% 198
2013
Q4 		$22.2M Buy
79,535
+33,088
+71% +$8.56M 0.2% 208
2013
Q3 		$11.2M Buy
46,447
+8,660
+23% +$1.94M 0.13% 256
2013
Q2 		$8.13M Buy
+37,787
New +$8.07M 0.1% 293

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Winton Capital Management's BIIB Position: Q1 2014 in Review

Winton Capital Management increased its Biogen (BIIB) stake by 27% in Q1 2014, buying an estimated $6.77M and bringing the position to 100,854 shares worth $30.8M. The position accounts for 0.21% of the portfolio, ranked #198.

Winton Capital Management first reported a position in BIIB in Q2 2013 and has held it in 4 quarters since. 776 funds tracked by Wall St. Rank hold BIIB as of Q1 2014.

  • Winton Capital Management held 100,854 shares of Biogen worth $30.8M as of Q1 2014.
  • Winton Capital Management bought 21,319 Biogen shares in Q1 2014, an estimated $6.77M.
  • Biogen made up 0.21% of Winton Capital Management's portfolio in Q1 2014, its #198 holding.
  • Winton Capital Management first reported a position in Biogen in Q2 2013 and has held it in 4 quarters since.
  • 776 funds tracked by Wall St. Rank held Biogen as of Q1 2014.

Based on Winton Capital Management's 13F filing for Q1 2014, filed 1 May 2014.